Protalex Inc. (OTCMKTS:PRTX) insider Arnold P. Kling bought 18,557,805 shares of the firm’s stock in a transaction that occurred on Wednesday, February 28th. The stock was bought at an average price of $1.20 per share, for a total transaction of $22,269,366.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of Protalex Inc. (OTCMKTS PRTX) opened at $0.55 on Monday. Protalex Inc. has a 12-month low of $0.31 and a 12-month high of $3.00.

TRADEMARK VIOLATION NOTICE: “Protalex Inc. (PRTX) Insider Arnold P. Kling Purchases 18,557,805 Shares” was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international copyright legislation. The legal version of this story can be viewed at

Protalex Company Profile

Protalex, Inc is a clinical-stage company. The Company is focused on the development of a class of biopharmaceutical drugs for treating autoimmune and inflammatory diseases, including rheumatoid arthritis (RA) and Immune Thrombocytopenia (ITP). The Company’s lead product candidate, PRTX-100, is a formulation of the Staphylococcal bacterial protein known as Protein A, which modifies aspects of the human immune system.

Receive News & Ratings for Protalex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Protalex and related companies with's FREE daily email newsletter.